A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft- versus -host disease: BMT CTN 0801 - Carpenter, Paul A.; Logan, Brent R.; Lee, Stephanie J.; Weisdorf, Daniel J.; Johnston, Laura; Costa, Luciano J.; Kitko, Carrie L.; Bolaños-Meade, Javier; Sarantopoulos, Stefanie; Alousi, Amin M.; Abhyankar, Sunil; Waller, Edmund K.; et al. (Haematologica (Roma), 2018)
Keywords: Aged; Calcineurin Inhibitors - administration & dosage; Chronic Disease; Disease-Free Survival; Female; Graft vs Host Disease - mortality; Graft vs Host Disease - therapy; Humans; Male; Middle Aged; Photopheresis; Prednisolone - administration & dosage; Sirolimus - administration & dosage; Survival Rate